All posts by medical

Leah Akins Named Top College of Nursing and Health Sciences Graduate at VSU – Valdosta State University News

May 4, 202020-40

Jessica PopeCommunications and Media Relations Coordinator

VALDOSTA Leah Suzanne Akins of Nashville, Georgia, is the recipient of the Spring 2020 Presidents Award for Academic Excellence for the College of Nursing and Health Sciences at Valdosta State University.

The Presidents Award for Academic Excellence is presented to the graduating student with the highest grade point average in each of VSUs six colleges Harley Langdale Jr. College of Business Administration, College of Nursing and Health Sciences, College of the Arts, James L. and Dorothy H. Dewar College of Education and Human Services, College of Humanities and Social Sciences, and College of Science and Mathematics.

Akins will be recognized during VSUs virtual 229th Commencement at 7 p.m. on Saturday, May 9, at valdosta.edu/commencement. She will graduate summa cum laude with a Bachelor of Science in Exercise Physiology.

It is truly an honor to be named the top graduate of my college, and in doing so, I am proud to represent VSUs Exercise Physiology Program, she said.

As a student at VSU, Akins was a member of the Exercise Physiology Club and a student intern at the campus-based Center for Exercise Medicine and Rehabilitation. She volunteered at the universitys annual Benefits and Wellness Fair and with Special Olympics, where she helped provide health services and education to athletes with intellectual and/or physical disabilities.

Akinss commitment to academic and service excellence resulted in her earning repeated spots on the Deans List, as well as the 2019 Blazer Creed Award of Civility and a free exam voucher to pursue American College of Sports Medicine Certified Exercise Physiologist credentials. She was also a Zell Miller Scholar.

Akins plans to continue her education in May at the University of St. Augustine for Health Sciences, where she will pursue a Doctor of Physical Therapy. Her dream is to establish a practice near her hometown and help rural Georgia citizens optimize their quality of life through prescribed exercise, hands-on care, and patient education. She is the daughter of Brion and Susan Akins.

Read more:
Leah Akins Named Top College of Nursing and Health Sciences Graduate at VSU - Valdosta State University News

Physicians’ Education Resource Will Host 1st Annual Live Medical Crossfire: IBS and IBD – Business Wire

CRANBURY, N.J.--(BUSINESS WIRE)--Physicians Education Resource (PER), a leading resource for continuing medical education (CME), will host the 1st Annual Live Medical Crossfire: Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD) symposium Saturday, June 27, as a full-day live CME-certified webcast.

We are excited to announce the launch of our new CME IBS and IBD program this summer, said Phil Talamo, president of PER. Gastrointestinal symptoms have such a huge effect on patients quality of life and social function, and our fast-paced symposium will provide gastroenterologists and primary care physicians vital insight and strategies on how to handle the types of cases that they often encounter in their own practices.

The educational symposium will be co-chaired by renowned experts William D. Chey, M.D., professor of internal medicine, gastroenterology and nutrition sciences and director of the gastrointestinal physiology laboratory and the digestive disorders nutrition and lifestyle program at Michigan Medicine, and Bruce E. Sands, M.D., M.S., professor of medicine and gastroenterology and chief of the division of gastroenterology at Mount Sinai Beth Israel.

The Medical Crossfire on IBS and IBD is a one-day interactive, scientific webcast that will help physicians assess the wealth of emerging data in treating IBS and IBD, choose appropriate treatment based on patient characteristics and apply novel management strategies to improve patient care. Led by distinguished experts in the field, the symposium will focus on key clinical topics in the management of IBS, IBD and chronic idiopathic constipation, as well as provide a unique opportunity for clinicians to learn from and interact with leading expert faculty to increase clinical knowledge; apply new data to practice; and, ultimately, improve patient outcomes.

Accredited by the Accreditation Council for Continuing Medical Education and approved by the California Board of Registered Nursing, this live webinar will provide participants the opportunity to earn up to 7.0 AMA PRA Category 1 Credits and 7.0 nursing contact hours.

For more information and to register, click here.

About Physicians Education Resource (PER)

Since 1995, PER has been dedicated to advancing cancer care through professional education and now advances patient care and treatment strategies on a wide variety of chronic illnesses and diseases. In 2016, PER initiated continuing medical education (CME) programming in the cardiovascular and endocrinology areas. While expanding into topics outside of oncology, PER stands as the leading provider of live, online and print CME activities related to oncology and hematology. The high-quality, evidence-based activities feature leading distinguished experts who focus on the application of practice-changing advances. PER is accredited by the Accreditation Council for Continuing Medical Education and the California Board of Registered Nursing. PER is a brand of MJH Life Sciences, the largest privately held, independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels.

Read more here:
Physicians' Education Resource Will Host 1st Annual Live Medical Crossfire: IBS and IBD - Business Wire

Genetics in focus after coronavirus deaths of siblings and twins – The Guardian

Amid the steady stream of stories on the lives lost to coronavirus are cases that stand out as remarkable. In the past month, at least two pairs of twins have died in Britain and two pairs of brothers, all within hours or days of each other. But do the deaths point to genetic factors that make some more likely than others to succumb to the disease?

Most scientists believe that genes play a role in how people respond to infections. A persons genetic makeup may influence the receptors that the coronavirus uses to invade human cells. How resilient the person is to the infection, their general health, and how the immune system reacts will also have some genetic component.

A team led by Prof Tim Spector, head of twin research and genetic epidemiology at Kings College London, has reported that Covid-19 symptoms appear to be 50% genetic. But Spector said more work is needed to understand which genes are involved and what difference they make to the course of the disease. We dont know if there are genes linked to the receptors or genes linked to how the infection presents, he said.

Identical twins Katy and Emma Davis, aged 37, died at Southampton general hospital last month. The sisters, who lived together, had underlying health problems and had been ill for some time before they contracted the virus. Another pair of twins, Eleanor Andrews and her sister Eileen, aged 66, died earlier this month. They too lived together and had underlying health conditions.

Two brothers from Newport, Ghulam Abbas, 59, and Raza Abbas, 54, died within hours of each other at Royal Gwent hospital. Another pair of brothers from Luton, Olume Ivowi, 46, and Isi Ivowi, 38, died within days of each other.

These deaths alert people to the fact that this could be genetic, but when people live together they share an environment as well, Spector said. The upshot is that twins who live together are more likely to have similar lifestyles and behaviours, from diet and exercise habits to how quickly they seek medical care. Twins are not generally less healthy than the wider population.

Twin deaths made headlines long before the coronavirus struck. When Julian and Adrian Riester died on the same day in Florida in 2011, a cousin of the twin Franciscan monks said it was confirmation that God favoured them. But Spector sees the hand of cold statistics at work. When you look formally at this, you see that twins rarely die at the same time, he said. There are billions of people on the planet. One in 70 is a twin and one in 200 is an identical twin.

Marcus Munafo, professor of biological psychiatry at Bristol University, said reports of twin deaths must be interpreted with caution. Twin deaths are unusual, which makes them newsworthy, but coverage can distort our perceptions. Salience bias refers to the fact that we tend to focus on information that stands out more, even if its not particularly relevant. So we need to be careful not to read too much into events that might stand out for reasons that are not actually related to the issue were interested in, he said.

When twins or siblings tragically die with Covid-19 that captures our attention, but that doesnt mean theres any particular reason to think twins or siblings are at greater risk.

Original post:
Genetics in focus after coronavirus deaths of siblings and twins - The Guardian

Software tool built by U of T startup shares genetic data with COVID-19 researchers around the world – News@UofT

One of the most puzzling things about the novel coronavirus is how it affects people in such different ways.

Among a single group of very similar people of the same age, some who contract COVID-19 will be asymptomatic, others mildly ill, while still others will be seriously sick and some will die.

Marc Fiume doesnt know why this is the case. The University of Toronto alumnus is a computer scientist, not a medical researcher. But he does know what the scientists studying the virus and developing treatments need: a near-constant flow of information.

So he and his colleagues at DNAstack are adapting their health-oriented search engine technology to a new tool that offers shared genetic data about COVID-19.

What we know about the virus is changing hourly as researchers and clinicians accumulate and analyze data, says Fiume, who earned his PhD, masters and bachelors degrees from U of T. So we are deploying our technologies at DNAstack to support researchers investigating the virus.

Dubbed COVID-19 Beacon, DNAstack launched their new tool in late March. Its a search engine that scans and indexes genomic information about the virusshared by scientists from around the world, making it possible for users to share and discover knowledge about the genetics of the virus in real time.

Researchers can then use the information a mix of the viruss genome (a complete set of genes) and other biological data to see how the virus is changing as it moves through the global population.

By sharing this genomic information over a cloud-based global network, there is the potential to improve knowledge of COVID-19 at a speed and scale that isnt otherwise possible, Fiume says.

That will contribute to new ways to fight the virus, such as the development of a vaccine.

Fiume launched DNAstack with partner Ryan Cook in 2014. The startup received support and guidance from U of T Entrepreneurship. As Fiume told MaRS Magazine two years ago, the inspiration to start the company came from his best friend, Dan, who has cystic fibrosis. Genetic disease is actually a very common problem. If you talk to anyone, within one or two degrees of separation they have someone in their family, or someone close to them, whos affected by a genetic disease. But given the complexity of individuals genetic make-up, Fiume said he quickly realized that his field computer science would play an important role in the search for treatments for genetic ailments.

Since then, the startup has built software to facilitate collaborative biomedical research and has partnered with leaders in cloud computing, sequencing, software and security to form the Canadian Genomics Cloud to further research discovery. DNAstack has also embarked on a partnership with Autism Speaks to enhance the agencys research portal. Through the collaboration, DNAstack organized one of the largest collections of autism genomes in the world and made them more easily accessible and able to be analyzed by researchers.

DNAstack has demonstrated remarkable leadership in its innovative and collaborative approach towards finding a solution for COVID-19, says Sue Paish, CEO of Canadas Digital Technology Supercluster, a cross-industry collaboration of diverse organizations, including DNAstack, that aims to position Canada as a global leader in digital technologies.

The global opportunity to aggregate, track and share real-time data across medical communities has enormous potential to unlock a cure for the virus.

DNAstack is getting noticed and supported, too. Prime Minister Justin Trudeau recently mentioned the company in his April 21 announcement about the bold ideas being put forth by groups working with Canadas Digital Technology Supercluster. And the companys COVID-19 tool was one of the winning submissions in Roche Canadas Open Innovation Challenge, which called for solutions to the challenges of the pandemic.

COVID-19 Beacon is a first step in DNAstacks efforts to support the research community with cloud-based tools for conducting research on the novel coronavirus.

This service is intended to help share data on COVID-19 as broadly as possible and connect a global ecosystem of data generators and researchers, says Fiume. Were urging researchers who are interested in making data available through this service, or using it for analysis, to get in touch with us.

Fiume notes that scientists developing drugs and vaccines for COVID-19 are in a much stronger position today because of the increasing sophistication of technology.

The technology is so much better than it was even five years ago. We now have better tools for cloud computing, more mature standards for data sharing and better frameworks for machine learning and the technology keeps improving. We also have a better ability to understand genetics and translate that into precision medicines.

While the world waits for a vaccine to be developed, Fiume says DNAstack will do what it can to help researchers in their quest. Were trying to do our part to minimize the impact of COVID-19, he says.

There is so much that scientists dont understand about this virus. Our job is to get people the information they need, so we can find solutions and get people back to normal.

See more here:
Software tool built by U of T startup shares genetic data with COVID-19 researchers around the world - News@UofT

Seattle Genetics’ bladder cancer med Padcev blows early expectations out of the water – FiercePharma

Even a pandemic cant slow Seattle Genetics new bladder cancer treatment Padcev downand analysts are jacking up their sales estimates for the drug as a result.

In its first quarter on the market after a mid-December FDA approval, the therapy blew out expectations exceeding consensus estimates" by four- to fivefold with $34.5 million in sales, J.P. Morgan analyst Cory Kasimov wrote in a note to clients.

Even SVB Leerinks Andrew Berens, whose Padcev sales projection wastwice as high as Kasimov's, noted that the drug handily beat our estimate of $10 million for the quarter, even in the midst of the pandemic.

Maintaining Momentum: Applying Recent Regulatory Guidance in the Midst of the Coronavirus

A panel of CATO SMS experts will review the key issues contained in the emerging Agency Guidance and offer thoughts on what changes and options for sponsors may be seen in the coming months.

And the performance was no fluke, either. While other drugmakers have seen their Q1 sales boosted by some stockpiling early in the pandemic, thats likely not what happened to Padcev, which follows a just in time delivery model that sees the drug delivered as-needed, Kasimov wrote.

RELATED:Seattle Genetics, Astellas snag quick FDA approval for bladder cancer fighter Padcev

Berens also cited assurances from SeaGens leaders that many of the patients who received Padcev in Q1 are still alive and receiving therapy. Management said it had no reason to believe this early adoption was driven primarily by a warehouse of end-stage patients which might have truncated duration of usage as has been seen with several other oncology drug launches.

If thats the case, many of these Q1 patients are likely to be on the drug in Q2 given the expected duration of treatment of about 4.5 months in this setting, Berens wrote, upping his 2020 target for the drug to $221 million and peak sales predictionin relapsed or refractory bladder cancer to $2 billion.

The thing is, SeaGen isnt stopping there. Its currently trying for a nod in previously untreated patients, an opportunity Berens pegs at $5.8 billion. And those SVB Leerink estimates dont even factor in potential revenue from earlier stages of the disease, such as muscle-invasive bladder cancer (MIBC), a sizable market the company is pursuing with a phase 3 trial testing Padcev alongside Merck immuno-oncology powerhouse Keytruda.

We estimate there are about 10,000 MIBC patients in the U.S., and the expected duration of therapy could be significant in these less advanced patients, Berens wrote.

But it wasnt all rosy news for Seattle Genetics in Q1, with Adcetrisuntil December its only approved drug, and a powerhouse with several indicationsnarrowly missing consensus estimates at $164.1 million.

More:
Seattle Genetics' bladder cancer med Padcev blows early expectations out of the water - FiercePharma

Exploring the Ethics of Genetic Testing: What Does Consent Mean? – Technology Networks

As with any medical procedure, to undergo genetic testing, informed consent must be given.According to the National Institutes of Health, informed consent (in the context of genetic testing) is the process of making sure that, wherever possible, a patient fully understands:

With this information, a patient can make an educated, voluntary choice i.e. they are informed to a level such that they can provide consent. This is usually a legal and ethical requirement in medicine.Whilst this might seem like a relatively simple concept, for genetic testing, informed consent suddenly becomes a whole lot more complex. Bioethicists, experts in the ethical practice of biology and medicine, often use case studies to explore these complexities and to discuss potential solutions to the dilemmas arising from them.

Jodie is a 28-year-old woman who is thinking about having children. However, she has a family history of limb-girdle muscular dystrophy and is considering undergoing genetic screening to determine if she is a carrier of any variants (a.k.a. mutations in her genome) associated with the disease.

Genetic Counselor Margarita Raygada, Ph.D., explains the role of a genetic counselor in cancer care and shares the benefits and implications of genetic testing for patients and their families.Genetic counselors are individuals educated in both medical genetics and counseling. This gives them the expertise to provide patients with the knowledge required to give consent, but also to offer guidance and support. As such, they are most likely the person who will be responsible for gaining informed consent from the patient.

Laura Hercher, Director of Research in Human Genetics at Sarah Lawrence College, has almost 20 years experience working as a genetic counselor. She emphasizes that the role of counseling goes far beyond testing alone:

Genetic counseling is about more than genetic testing. It can obviously be about that, and a genetic counselor would be a good person to discuss genetic testing with, but we meet with people where genetic testing isn't on the table at all.

I think that there is an element of education in many genetic counseling sessions or interpretation but also in many circumstances, theres what we call establishing a therapeutic relationship, where you do the counseling side of it.

Continuing on this theme, Hercher points out a key aspect of genetic counseling and something which is crucial to the consent process but often forgotten amongst the hype surrounding genetic testing.

We [genetic counselors] don't take for granted that somebody will want genetic testing. They have the right to say no these are shared norms in genetics in the UK and the US.

However, in Jodies case, she has expressed interest in genetic testing. How does a genetic counselor go about establishing informed consent for this?

You have to consider both of these two very basic things, Hercher begins. Make sure the person has an understanding of what genetic testing may tell them and also have an understanding of what genetic testing may not tell them.

These are very important to understand because, number one, you don't want someone to walk away from the experience saying, "Okay, great, I've been tested. I don't have a disease, if that isn't comprehensive.

Number two, we want to talk about what the test will show the patient, both in terms of setting up correct expectations that's consent but also by identifying additional things they might find out that are not necessarily the goals of testing.

The blood sample provided by Jodie undergoes whole exome sequencing. Upon sequence analysis, its found that Jodie does not have any of the variants currently associated with limb-girdle muscular dystrophy. However, the person analyzing the data also checks for other common disease-associated variants. They discover that Jodie has a mutation in BRCA2 that puts her at a higher risk of developing breast and/or ovarian cancer.

The discovery described above is known as a secondary finding, meaning that whilst its identification may not have been the main goal of the test, its presence was actively sought. This is different to an incidental finding, although the terms are often used interchangeably.The potential for secondary findings demonstrates how consent in genetic testing isnt as simple as a single yes or no answer. The decision to actively look for other variants and have them reported back provides an additional layer of consideration to the consent process.

In 2013, the American College of Medical Genetics and Genomics (AMCG) published recommendations for the responsible handling of incidental findings emerging from clinical exome or genome sequencing. This includes clinicians being responsible for alerting patients to the possibility that sequencing could result in incidental findings, and that these may warrant further investigation.1A proper informed consent for genetic testing would give the person a notion of what they might encounter as a part of testing, and what choices they have, about what [testing or results] they can get and what not to get, if there are choices available in the setting in which you're operating.

Jodie doesnt just have a decision to make about whether or not she wants the test, she also has to consider what results she would want reported back to her. The availability of choice is an important one because of the potential implications, both physically and mentally, of being given information you werent expecting or didnt want to receive.

Jodies results show that she, and potentially her first-degree relatives, are at a high risk of developing breast and/or ovarian cancer. Although it isnt a guarantee that she would develop those diseases, this knowledge could impact upon decisions she makes about her healthcare. For people carrying a disease-associated BRCA mutation, preventative, albeit drastic, surgical measures may be available, including mastectomies and oophorectomies.

Preventative surgery, or even just knowing that you may develop a disease can also take an emotional toll. In addition, a patient could find out that they have variation that means they will develop a condition at some point in their lifetime, such as Huntingtons disease. This may have an impact on mental health if there are currently very limited or no treatment options for the condition diagnosed, although further and continual research needs to be conducted to assess the extent of such an impact.

Secondary findings can also emerge with advances in research; a variant that may not have been considered a pathogenic variant before could be considered so in the future, or vice versa. Patients like Jodie would need to think about whether they would want to be re-contacted with new or updated information.

Thats a lot of factors for someone to consider before consenting. How can we simplify consent to account for all of those decisions and outcomes, if its even possible?

This requires time something which the healthcare system doesnt always have enough of. How do we create a process that works for both clinicians and patients?

The answers people are coming up with tend to be that we need better tools, Hercher tells me. And that includes online or digital tools that would allow people to interact with the information. You know, if you sit somebody down and spout off 15 minutes worth of information, dense information, you're not doing anything for them.

So, what's needed to improve the situation is new tools that allow people to tackle it over time, at their own pace, exploring what they want to and when. That would optimize the situation for both the caregiver and the patient. And allow them to go back to it [the information] to refresh their memory and so on. The optimal consent process is not "let's decide everything we can fit into this space of time consent, optimally, is an ongoing process.

Research conducted in the UK seems to agree. A recent report from the Joint Committee on Genomics in Medicine sums it up nicely:Consent may be more appropriately seen as an ongoing conversation that needs updating and clarifying where necessary, rather than as a single historical event that needs to be revisited.Reference

View original post here:
Exploring the Ethics of Genetic Testing: What Does Consent Mean? - Technology Networks

Genetic diversity in India’s lions is dangerously low, and that’s a big problem – Research Matters

Study traces the evolution of extinct and living lions through genes and provides hints for conservation.

Disneys 1994 animated film, The Lion King, immortalised the character Simba, a young lion cub, and intrigued many into the lives of lionsmajestic cats now restricted to only parts of Africa and India. It may be a surprise to learn that, not long ago, they were found all over the world! About fifteen thousand years ago, the cave lions of Eurasia, the American lions of North America, the Barbary lions of North Africa, the Cape lions of South Africa, along with todays lions, roamed the planet. Their extinction started with the cave lions about 14,000 years ago. In the last 150 years, humans have wiped off the Barbary lions and the Cape lions, hunting them to extinction.

Today, a curious question in science is to know how these different types of lions evolved and how different are todays lions from their ancestors. In a new study, an international team of researchers have tried to answer these questions by analysing the genes of extinct and living lions. The study, published in the Proceedings of the National Academy of Sciences (PNAS), finds that about 500,000 years ago, modern and now-extinct lions shared a common ancestor. Further, about 70,000 years ago, two different lineages of modern lions emerged. The findings also have implications on the conservation of the remaining lion population, which is just 10% of what it was a century ago.

Lions are absolutely a keystone species, and the health of lions generally reflects the health of the total ecosystem, says Dr Ross Barnett from the University of Copenhagen, Denmark. An author of the present study, he has worked on cat genetics for years. Studying lions gives us an excellent big picture of general trends, he adds.

Most previous studies on understanding the evolution of lions used mitochondrial DNA that is present in the mitochondria of the cell and has limited information. In the current study, the researchers have used the complete DNA sequence, extracted from 30,000-year-old fossil samples, century-old samples and live individuals. These included the cave lions (Panthera leo spelaea), and modern lions (Panthera leo leo) found in Africa and India.

We looked at it from the whole genome angle. This allows us to get not only a robust answer on how the different populations of lions relate but also study the diversity in the remaining populations, says Dr Thomas Gilbert. He is a professor at the University of Copenhagen and a co-author of the study. The new results illustrate the power of the genomics in revealing lost secrets of prehistory by reading the DNA footprints of ancient and modern species, says another co-author Dr Stephen J. OBrien from Nova Southeastern University, USA.

The study found that until about half a million years ago, the cave lions, which lived in cold regions, and the modern lions, shared a common ancestor. This finding is consistent with other fossil evidence. Any evidence of a hybrid between cave lions and modern lions seemed to be absent. The modern lions split up into two distinct north and south lineages about 70,000 years ago, with Africa being a melting pot of these ancestries. The northern lineage, found north of the Sahara, includes lion populations from North Africa and West Africa. In contrast, the southern lineage includes sub-Saharan lions found in Central, East and South Africa.

Indian Lions: Genetically least diverse

Among the samples studied by the researchers were Asiatic lions from the Gir forests, the only home for wild Asiatic lions. The study, although traced the origins of Asiatic lions to the northern lineage, found that they shared a fifth of their genetic structure with the southern lineage. However, it found no evidence that these lions were recently introduced from outside India. But one of the most alarming findings of the study was how less the genetic diversity was among the Asiatic lions.

A family of Asiatic Lions in Gir [Image Credits: By Shubhammahla19 - Own work, CC BY-SA 4.0]

They are well known to be very inbred as the population is tiny, says Dr Gilbert. Their analysis found that the two samples of Indian lions were almost identical, with inbreeding as a result of dwindling numbers since the 18th century. By the 20th century, only twenty lions remained in the Kathiawar Peninsula in Gujarat. The risks are that there could be both an elevation of deleterious mutations in the population, and a lack of diversity in things like the immune system-related genes, warns Dr Gilbert.

These findings have enormous implications for the conservation of these charismatic lions across the world, and especially for the vulnerable populations in Gir.

In theory, it might be argued that theyd be at least biologically fitter if some genetic diversity was introduced. Possibly, from one of the other related populations outside India, explains Dr Gilbert. But scepticism galore. For one, lions in India are seen as the pride of the country and many would not want to see them polluted with non-Indian lineages.

Besides, such introductions of non-native species have had worse outcomes. For example, when new wolves were introduced on Isle Royale, in the US, to conserve the native ones, the previously inbred wolf population crashed.

Genetic studies, like the one here, can also stir up conversations on conservation.

If you want to help fix species in trouble, through management, you need to know what the population looked like originally to make informed decisions, says Dr Gilbert. These findings help at analysing the direct impact of the last 100+ years on the species and its genome. This ability did not exist before. For example, we see in the South African lions a very measurable loss of diversity during this time. We know humans impact the genetic diversity of species. Now, we can start quantifying it and maybe use that for future management, signs off Dr Gilbert.

This article has been run past the researchers, whose work is covered, to ensure accuracy.

View original post here:
Genetic diversity in India's lions is dangerously low, and that's a big problem - Research Matters

How To Interpret Genetic Predisposition For Weight Gain From DNA Kits – Women’s Health

Adriana Romero-Olivares signed up for 23andMe about seven years ago because she was curious about her ancestry. But the DNA testing company sends updated reports to its customers as it develops them, so in 2018, Adriana received an email notifying her that she had a new report available: a Genetic Weight report. She clicked, and it told her, Adriana, your genes predispose you to weigh about 9 percent more than average.

Learning that info was a strange pill for her to swallow. Ive struggled with my weight my entire life, says Adriana, 35. When I got the results, I felt validated, but then at the same time, I felt upset, because I struggle to accept the fact that I just can't be thin.

Over the past few years, DNA testing companies have started churning out reports like that one that specifically tell someone their likelihood of becoming overweight or obese. The thing is, getting bold text in your inbox that says you have a higher propensity to gain weight than the other people in your HIIT class can feel like a bit of a bomb, as Adriana points out.

So how reliable are these reportsand can they actually aid your efforts if you're trying to lose weight? Heres what experts have to say.

Just from pure observation, you can tell that theres a genetic component because you can look at families and see that weight gain runs in families, says Rachel Mills, a certified genetic counselor and assistant professor in the University of North Carolina-Greensboro Genetic Counseling Program. Beyond that, it gets more complicated.

Researchers dont have a firm answer in terms of to what degree being medically overweight or obese is influenced by genetics, compared to lifestyle and environmental factors. They've estimated that anywhere from 40 to 70 percent of person-to-person variability in body mass index (BMI) is due to genetic factors. (Obvious alert: Thats a wide range.)

And while researchers have already discovered hundreds of genetic variants associated with BMI, weve only got a partial picture of the genetic component so far, says Struan F.A. Grant, PhD, director of the Center for Spatial and Functional Genomics at Childrens Hospital of Philadelphia. Grant notes that BMI is a very polygenic trait, which means there are many, many genetic factors contributing to the trait, he explains. Each genetic variant could have a somewhat different effect on BMI, toothats something experts are still figuring out.

Just because a genetic report says that you are less likely to lose weight, that is not an absolute. Rachel Mills, genetic counselor

So what does it mean if a person has several genetic variants associated with obesity? Once we have a more complete picture of how genes drive obesity risk, we could eventually be able to get data (say, from our doctor) that helps guide how we approach weight management on a personal level, Grant says. But right now, all we definitely know is that certain genetic variants are more common in obese people compared to non-obese people.

23andMes Genetic Weight reports even explain right under your results that your predisposition doesnt mean you definitely will weigh more or less than average. 23andMe senior product scientist Alisa Lehman says that, in 23andMes model, the genetic component [accounts for] less than 10 percent of what the total difference in weight between any two people is. The company does extensive user testing before releasing reports that delve into new areas, she says. And, in this case, they wanted to make sure that customers have an understanding that genes are only one factor in weight management.

How businesses gather weight predisposition info varies company to company. For example, health-focused DNA testing and supplement company Vitagene and weight-loss platform Lose It! use results from other institutions research papers to internally calculate a persons risk of becoming overweight. (Lose It! also asks you to input your AncestryDNA or 23andMe raw DNA filesthe company doesnt do its own DNA testing.)

But 23andMe, arguably the most well-known service, uses its own data to come up with a persons weight predisposition. We have a research program that allows people to answer questions and then, from that, if they opt in, we can use their data to make new genetic discoveries, Lehman explains.

23andMe researchers released the Genetic Weight report in March 2017. They created it by looking at data from more than 600,000 research participants, including their DNA and self-reported height and weight. (Check out a sample report here.)

23andMe researchers found 381 variants associated with BMI, and used that info to create a modeling process that weighs certain variants more strongly than others and considers age, sex, and ancestry to determine the result they send to a consumer. "So when people provide us their saliva sample and we gather their DNA, we can look at those 381 places and say, 'Hey, okay, you have some variants that increase your predisposition and some variants that decrease your predisposition, and the magnitude of each of those variants differ a little bit,'" explains Lehman. "But we add up the effect of all of that to get a sense of whether your predisposition is to [weigh] a little bit more or a little bit less than average."

Depending on your ethnicity, there might also be another caveat. The largest population that 23andMe has data for is people of European descent, so researchers were only able to look at genetic and BMI data from people of European descent to identify the weight-related genetic variants and their effects. Then they looked at how well that model worked for people of other ethnicities, tweaking the model as necessary. Therefore, people who have Latino, African American, East Asian, and South Asian ancestry can get results that are somewhat customized to their ancestry, while people of mixed ancestry or other ancestries default to European. (This Eurocentric bias comes up in a *lot* of research that scans peoples genomes for genetic variants associated with a disease or trait, not just in relation to BMI.)

It doesnt appear that any companies that provide weight-related DNA results have conducted any formal research on how the info impacts peoples weight-loss efforts. Lehman says 23andMe has looked a little bit into whether the information in the Genetic Weight report has actually helped consumers with weight loss or management, but that they havent come up with anything "publication-worthy," adding that its challenging to untangle this report from other info the company provides on nutrition and exercise.

23andMe also hasnt taken a fresh look at their Genetic Weight report model since releasing it, but it plans to. We do periodically review all of the reports that we have, and Genetic Weight is coming up for that periodic review, so we will soon review it and see if any updates are warranted, Lehman says.

23andMes Health + Ancestry Service

This product includes a Genetic Weight report that tells you how much more or less than average your genes predispose you to weigh. It also explains that your predisposition doesnt mean you definitely will weigh more or less than average. Keep in mind that your lifestyle and environment have a big impact on your weight, the report reads.

HomeDNA Healthy Weight

This report tells you your general weight loss ability with diet and exercise. On a page explaining those results, the report reads: "Remember that these results only indicate your potential based on genetic factors, but many other factors also affect the outcome."

Lose It! Premium

Once you upload your AncestryDNA or 23andMe raw DNA file, this platform will tell you whether or not you have a genetic risk of being overweight or obese. In a disclaimer, the report says, These genetic variants are not perfectly predictive. You may have a high genetic score and a low BMI, or a low genetic score and a high BMI. These results may be more accurate for people of certain ethnic backgrounds.

Vitagenes Health + Ancestry DNA Tests and Reports

Customers can learn whether their genetics may make them more or less likely to become overweight with this kit. The info includes this caveat: However, your genetics alone dont define your body weight. Making healthy lifestyle choices may help keep you from becoming overweight. (Customers also have the option to upload their own raw DNA results for $29.)

Of course, some people might just like or even be motivated by having more information about themselves, and thats totally fair. But heres an interesting twist: A recent study out of Stanford University found that just knowing your genetic risk for obesity can impact the way you respond to food.

In one of two experiments, participants ate a meal and then, on a different day, ate another after hearing that they did or didn't have a high-risk genetic variant associated with obesity and lower satiety. Heres the catch: Researchers chose randomly whether participants would be told they had the genetic variant. (The researchers fully debriefed the participants about their actual genetic risk only about an hour later, while they were still under clinical supervision.)

We saw that the information we gave to people was like a self-fulfilling prophecy, says Brad Turnwald, PhD, a postdoctoral research fellow in the department of psychology at Stanford University and lead author of the study. When researchers told people they didnt have an increased risk, they reported feeling full faster and even produced more of a fullness hormone. Overall, what we saw was that what people thought had as much of an impact, and in some cases a greater impact, than what peoples actual gene sequence was, Turnwald says.

The takeaway, says Turnwald, is that we need to better understand the psychological impact of these kinds of DNA test products. We're definitely not trying to say that genes don't matter at all. There are some diseases for which they really are predictive, he says. But for the majority of things like weight loss and how hungry we are and how well we exercisethings for which people are looking for explanations that they just weren't made to run or they just don't feel full based on their genesthe story is not going to be that simple.

Mills doesnt believe that its possible for any sort of calculation to exist at the moment that can accurately analyze a persons propensity to gain weight. If someone told her they were interested in one of these reports, she would ask them to think seriously about how you would use that information, Mills says.

I know, for me personally, I would see a report [that says I cant lose weight as well through diet and exercise] and maybe throw up my hands and be like, Well, Im just going to go to McDonalds because it doesn't matterno diet and exercise is ever going to help me lose weight, so why do I need to even try she continues. And that can have a really detrimental effect.

If someone has already received genetic weight report results and asked her how to interpret themor wants to know how damning they actually are, so to speakMills would emphasize this: Genetics is just one piece of the big picture, she says. Just because this genetic report says that you are less likely to lose weight, that is not an absolute.

Adriana is Mexican, and shes also a scientist, so she knows that she should take her reported propensity to be overweight with a grain of salt. She says her Genetic Weight report is one piece of information, an indicator that I tend maybe to gain weight or that my metabolism is not as fast as the average persons, she says. But shes not going to make major lifestyle changes based on it.

Over time, though, the report has had a positive effect on Adrianas mindset: The way that I think about it now is, if Im predisposed to weigh a little bit more than the average person, then I might as well just exercise and have a balanced diet for the sake of health and not necessarily for the sake of losing weight, which, for a very long time, was the main focus for me.

Follow this link:
How To Interpret Genetic Predisposition For Weight Gain From DNA Kits - Women's Health

UMass Amherst Student Speaker Grace Jung to Help Lead Virtual Celebration for Class of 2020; 21st Century Leaders Selected – UMass News and Media…

AMHERST, Mass. Student Speaker Grace Jung of the University of Massachusetts Amherst will play a leading role Friday during a virtual celebration of the universitys Class of 2020.

Jung, whose hometown is Newton, was selected as the student speaker for the virtual celebration and for an in-person commencement to be held at a later date. She is a biochemistry and molecular biology major who plans on applying to dental school with the goal of becoming a pediatric dentist. She has volunteered through the UMass Center for Women and Community as a Massachusetts-trained rape crisis counselor and has been involved in the UMass Pre-Dental Society and the American Student Dental Association. Jung also was co-manager of the student-run business Campus Design and Copy.

The culminating virtual event honoring the achievement of this years graduating class will be available on Friday, May 8, at 4:30 p.m. EDT atwww.umass.edu/UMass2020. During the 15-minute streaming video celebration, Chancellor Kumble Subbaswamy will lead a tribute that honors the graduating class.

In addition, the university has selected 10 members of the Class of 2020 as 21st Century Leaders for their exemplary achievement, initiative and leadership:

Nathalie Amazan of western Long Island, New York, is a Commonwealth Honors College student with a double major in political science and legal studies with a minor in Afro-American studies. Recognized as a student leader, Amazan served as a member of the Student Government Association, rising to the position of vice president. She also founded the UMass Restorative Justice Initiative through her fellowship with Young People For and a partnership with the UMass Center for Education Policy and Advocacy to bring a restorative justice program to campus. She co-founded the UMass Prison Abolition Collective in 2016 and served on the W.E.B. Du Bois Afro-American Studies Undergraduate Council. She has worked as an intern for the UMass Student Legal Services Office and the ACLU. Her plans are to take the LSAT this summer and start law school in 2022 after doing legal advocacy work in New York and continuing to write and perform poetry.

Racquel Bitar is a Commonwealth Honors College student graduating with a degree in microbiology and a minor in anthropology. The Paxton native has worked as a research assistant for Professor Mark Pachuckis research group in sociology and in Professor Luke Remage-Healeys lab in psychology and brain sciences, as a resident assistant, a teaching assistant in biology, a medical scribe at the UMass Memorial Medical Center and as a career peer advisor in the College of Natural Sciences. Bitar also volunteers as a court appointed special advocate in Worcester, work she intends to continue while serving as a medical scribe as she applies to medical school. She is a member of Phi Sigma Pi, a national honor fraternity and the Arab Cultural Association, where she served as public relations officer and treasurer.

Christopher Clark of Westfield, a Commonwealth Honors College student receiving a degree in environmental science and STEM-German, plans to pursue a masters degree in environmental health sciences from the University of Michigans School of Public Health and eventually a Ph.D. Clark worked in the research lab of Professor Alicia Timme-Laragy in environmental health sciences doing toxicology research. Clarks leadership experience includes working on the steering committee and as a community organizer for Westfield Residents Advocating for Themselves, which led an effort that resulted in a CDC-sponsored exposure assessment and an increase in regulation for per- and polyfluoroalkyl substances (PFAS). Clark also served on the Student Government Association as chief of staff and undersecretary of sustainability. He has received numerous academic awards, including a Benjamin A. Gilman International Scholarship awarded by the U.S. State Department to study abroad in Germany.

Jonathan DeMarco of Hopkinton is a civil/environmental engineering major who will begin work as an environmental engineer in New York City upon graduation. He plans on studying for a masters degree from UMass Amherst as well. DeMarco has worked as a student ambassador in the deans office of the College of Engineering and worked as an engineering study abroad essentials coordinator with the International Programs Office (IPO) at UMass to implement a long-term IPO program that will assist engineers to engage in study abroad. He was involved in the Engineers Without Borders chapter on campus and traveled to Kenya and Ghana to assist communities by implementing various water-related infrastructure.

Deanna Ferrante of Carver is a Commonwealth Honors College student and a psychological and brain sciences major with a minor in education and a letter of specialization in developmental disabilities and human services. She interned at the National Organization on Disability, where she was awarded the Kaitlin Geraghty Memorial Prize for excellence in disability inclusion, and at the Assistive Technology Center at UMass. Ferrante also worked as a resident assistant and received numerous academic awards, including Outstanding Overall Senior from the department of Psychological and Brain Sciences. Ferrante founded the Alliance Against Ableism, an on-campus activism group that advocates for people with disabilities. Her future plans include working for an asset management firm as a human resources analyst and exploring post-graduate opportunities in industrial-organizational psychology.

Victoria Ishola of Worcester will receive a bachelors degree in business administration in finance from the Isenberg School of Management. Her plans are to work for a couple of years in the private sector before pursuing a law degree. At UMass, Ishola served as secretary of finance for the Student Government Association, the first black female student to do so, and reformed various financial processes within SGA. She also was voted in as UMasss first black Homecoming queen in 2018 and worked as a resident assistant. Ishola also is a member of the Alpha Kappa Alpha sorority and participated in the UMass Black Mass Communication Project as its treasurer. Ishola says that being a student leader in the Black community on campus helped her advocate for less-seen campus groups and to remind other students of color not to be limited by one or more of their identities.

Carl McDonald of Carmel, N.Y., is a Commonwealth Honors College student majoring in nursing. McDonald worked as a resident assistant and UMass tour guide for the admissions office. He is the social actions coordinator for the Student Nurses Association on campus and worked as a nurse extern at the New York-Presbyterian Psychiatry hospital last summer, where he received a Tier III Award for saving a patients life by performing the Heimlich maneuver. His career goal is to move to New York City and work as an oncology nurse and eventually study for a psychiatric nurse practitioner degree to work with patients suffering from substance abuse disorder or schizophrenia. He published an article with faculty on end-of-life knowledge among university nursing students and presented on the same topic at national nursing conferences.

Daniela Molina Palacios, a Commonwealth Honors College student and member of Phi Beta Kappa, is graduating with a degree in biochemistry and molecular biology. A native of Venezuela, Palacios has participated in the Massachusetts Institute of Technology (MIT) COVID-19 Challenge in April, assisting with UbiquiTest, a virtual platform that can advise healthcare professionals and companies on which populations can benefit from group testing. Shes also worked as a summer research intern at MIT and in the lab of Professor John Stoffolano, with whom she did her honors thesis. She also worked as a teaching assistant in biochemistry, a resident assistant and an academic peer advisor in biochemistry and molecular biology. Palacioss leadership extended to projects off campus as well, where she served as a tutor for Eureka! Girls Inc. in Holyoke. She also was a member of the Workplace Climate Committee in biochemistry and molecular biology. Her future plans include working as a research associate at MIT and eventually pursuing a Ph.D.

Jeremy Paradie of Holliston is graduating with a bachelors degree in individual concentration (BDIC) in creative mechatronics, a multidisciplinary branch of engineering that focuses on both electrical and mechanical systems. While at UMass, Paradie started in the electrical and computer engineering program, but he transitioned based on his interest in a more interdisciplinary experience to the BDIC program, where he could design his own major and extend his learning experiences beyond engineering and into landscape architecture, theater and the cognitive sciences program at Hampshire College. Working with faculty in landscape architecture, Paradie helped with several interactive walkway projects, including one called Step and Flash, which created a piezoelectric walkway with a goal of harvesting energy from footsteps. He also contributed to a temporary installation called FutureWATERS along East Bostons greenway. On campus, Paradie worked at the All-Campus Makerspace and managed the M5 Makerspace for electrical and computer systems engineers. He was a teaching assistant at Hampshire College and in landscape architecture. He has participated in several hackathons and maker fairs. His future plans include graduate school.

Timothy Scalona is a Commonwealth Honors College student with a double major in political science and a BDIC in policy, journalism and storytelling with a minor in Spanish from Wilmington. He has worked as a resident assistant and is the founder of the First-Generation Low-Income Student Partnership, which advocates for centralized campus support systems for first-generation, low-income students. Scalona has written about and been featured in the media as a previously homeless college student and did his senior thesis on the Massachusetts Emergency Assistance program and his familys experiences in it. He also served on the Student Government Association and chaired its Social Justice and Empowerment Committee. He has worked as a caseworker intern at Amherst Community Connections, assisting homeless individuals with job and housing searches, and as a district intern for former State Rep. Solomon Goldstein-Rose of Amherst. Scalona is a member of the Alpha Chi Rho fraternity and helped lead efforts to support the UMass student food pantry and other projects for low-income students. His future plans include pursuing a masters degree in public policy at UMass Amherst and eventually applying to law school.

See the original post:
UMass Amherst Student Speaker Grace Jung to Help Lead Virtual Celebration for Class of 2020; 21st Century Leaders Selected - UMass News and Media...

‘Foundational for the Development of the Field’ | The UCSB Current – The UCSB Current

The UC Santa Barbara Academic Senate has awarded Distinguished Professor Alison Butler the Faculty Research Lecture Award for 2020.

I congratulate Alison on receiving the highest honor bestowed by UC Santa Barbaras faculty senate, said Pierre Wiltzius, executive dean of the College of Letters and Science. As a pioneer in the field of metallo-biochemistry, and a leading scholar on this campus, she is most deserving of this recognition.

Said Steve Buratto, professor and chair of the chemistry and biochemistry department, Professor Butler is one of our most highly decorated faculty members. For over 30 years she has exemplified what is to be a truly great researcher: highly creative with an interdisciplinary spirit coupled with hard work. Her colleagues in the Department of Chemistry and Biochemistry are very proud of her and can think of no one more deserving of this award.

Im so grateful, Butler said, I couldnt have found a better department to have started my career, and in fact to have actually developed my whole career.

Butlers research focuses on bio-inorganic chemistry with an emphasis on the roles of metal ions in metallo-enzymes. Although the topic may seem obscure, its of no small importance. All life depends on metallo-enzymes to function, Butler said, from breathing to photosynthesis to nitrogen fixation.

She is particularly curious about the molecules and processes by which microbes acquire the transition metals they need to grow, which can be quite difficult to obtain from the environment. Transition metals are often locked away in oxides and minerals or in the complex proteins of host organisms.

To acquire the metals they so desperately need, many bacteria secrete small molecules called siderophores that scour the surroundings of a particular metal, most often iron. Butler is working to predict the forms and functions of these molecules using genomics, as well as what other metal ions microbes may sequester using these and other microbial ligands.

Butler suspects these small molecules may have additional functions as well, completely unrelated to metal sequestration. For instance, she and her colleagues are looking at the wet adhesion properties of siderophore cyclic trichrysobactin, which resembles and mimics the proteins that keep mussels secured to rocks.

With its unique chemistry and signs of applicability to fields such as materials and medicine, this subject has begun to attract a number of other researchers. I feel like we played a small part in opening up the excitement and importance of metallo-biochemistry and bio-inorganic chemistry of the marine environment, Butler said.

She is the recipient of numerous honors and awards, including the American Chemical Societys Alfred Bader Award in 2018 and the Cope Scholar Award the following year. The society generally specifies a five-year span between awards unless each award recognizes distinct achievements, making Butlers recognition truly exceptional.

Also in 2019, she was elected Fellow of the American Academy of Arts and Sciences as well as of the Royal Society of Chemistry, who additionally bestowed upon her the societys Inorganic Reaction Mechanisms Award.

Butler has mentored 37 doctoral students and postdoctoral scholars, many of whom have gone on to develop stellar careers of their own. She has found time to share her leadership capability with the campus, serving as the vice chair of the chemistry department, associate dean of bioengineering, and currently as associate vice chancellor for academic personnel.

In announcing the Faculty Research Lecture Award, the committee noted Butlers seminal contributions to research, citing her for having expanded the field of siderophore research, discovering new classes of siderophores, and new reactivity of the iron(III)-siderophore complexes. Of specific note was her discovery of the photoreactivity of Fe(III)-bound to siderophores with alpha-hydroxy carboxylic acids. Researchers have worked with some of these compounds for 40 years without ever recognizing this property.

To quote one of Butlers nominators: Her work is foundational for the development of the field and the understanding of biological productivity on Earth.

Butler looks forward to sharing her enthusiasm for bio-inorganic chemistry with the community when she gives her lecture. As daunting as it feels, when I actually get down to thinking about how to present this, Im really excited, she said. She hopes to include audience participation and demonstrations in her lecture.

Reflecting on her selection for the Faculty Research Lecture Award, Butler said, Its totally special because its really my immediate community. Who knew, when I started off at UCSB as an assistant professor in 1986, that this is where I could get.

See the rest here:
'Foundational for the Development of the Field' | The UCSB Current - The UCSB Current